John S Kim,Catherine L Debban,Daniel Guzman,Riley T Hannan,Mary Salvatore,Claire McGroder,David Zhang,Anna J Podolanczuk,Daniel A Duprez,Shwu-Fan Ma,Yong Huang,Jeffrey M Sturek,Stephen S Rich,Jerome I Rotter,Rajat Deo,Ruth F Dubin,Janelle Vu Pugashetti,Jennifer M Wang,MeiLan K Han,Justin M Oldham,Imre Noth,Prescott G Woodruff,Victor E Ortega,Julie C Fanburg-Smith,Edward B Stelow,Christopher A Moskaluk,Eric A Hoffman,Christine Kim Garcia,Russell P Bowler,Peter Ganz,R Graham Barr,Ani Manichaikul
{"title":"Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities.","authors":"John S Kim,Catherine L Debban,Daniel Guzman,Riley T Hannan,Mary Salvatore,Claire McGroder,David Zhang,Anna J Podolanczuk,Daniel A Duprez,Shwu-Fan Ma,Yong Huang,Jeffrey M Sturek,Stephen S Rich,Jerome I Rotter,Rajat Deo,Ruth F Dubin,Janelle Vu Pugashetti,Jennifer M Wang,MeiLan K Han,Justin M Oldham,Imre Noth,Prescott G Woodruff,Victor E Ortega,Julie C Fanburg-Smith,Edward B Stelow,Christopher A Moskaluk,Eric A Hoffman,Christine Kim Garcia,Russell P Bowler,Peter Ganz,R Graham Barr,Ani Manichaikul","doi":"10.1164/rccm.202503-0610oc","DOIUrl":null,"url":null,"abstract":"RATIONALE\r\nHigh attenuation area (HAA) is a computed tomography (CT) tool that correlates with lung inflammation and fibrosis. Systemic molecular correlates of HAA (e.g., plasma proteins) may inform biological process involved in interstitial lung disease (ILD).\r\n\r\nOBJECTIVES\r\nIdentify plasma proteins that associate with HAA and correlate with a higher probability of developing new-onset fibrotic or subpleural interstitial lung abnormalities (ILA).\r\n\r\nMETHODS\r\nPlasma protein levels were measured using a semiquantitative aptamer-based platform in the Multi-Ethnic Study of Atherosclerosis (MESA, n=5486) and Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS, n=1761). Linear regression models identified HAA-associated proteins after adjustment for demographic and socioeconomic factors, CT scanner parameters, study center, and batch. Associations of HAA-related proteins with new-onset fibrotic or subpleural ILA were examined in MESA participants with ILA assessments on full-lung CT 10 years later. Immunohistochemical staining of select proteins was performed in lung tissue from pulmonary fibrosis cases.\r\n\r\nMEASUREMENTS AND MAIN RESULTS\r\nThere were 75 proteins detected that were significantly associated with HAA in MESA and SPIROMICS. Gene ontology analysis of these proteins identified processes involved in immune cell chemotaxis and cellular growth and apoptosis. Seven proteins were associated with a higher probability of new-onset fibrotic or subpleural ILA in MESA and two of these, junctional adhesion molecule-like protein and GTP cyclohydrolase 1 feedback regulatory protein, stained in areas of fibrosis in lung tissue from patients with ILD.\r\n\r\nCONCLUSIONS\r\nPlasma proteins associated with more HAA are involved in immune and cellular processes and associate with new onset fibrotic-subpleural ILA.","PeriodicalId":7664,"journal":{"name":"American journal of respiratory and critical care medicine","volume":"28 1","pages":""},"PeriodicalIF":19.4000,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of respiratory and critical care medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1164/rccm.202503-0610oc","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
RATIONALE
High attenuation area (HAA) is a computed tomography (CT) tool that correlates with lung inflammation and fibrosis. Systemic molecular correlates of HAA (e.g., plasma proteins) may inform biological process involved in interstitial lung disease (ILD).
OBJECTIVES
Identify plasma proteins that associate with HAA and correlate with a higher probability of developing new-onset fibrotic or subpleural interstitial lung abnormalities (ILA).
METHODS
Plasma protein levels were measured using a semiquantitative aptamer-based platform in the Multi-Ethnic Study of Atherosclerosis (MESA, n=5486) and Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS, n=1761). Linear regression models identified HAA-associated proteins after adjustment for demographic and socioeconomic factors, CT scanner parameters, study center, and batch. Associations of HAA-related proteins with new-onset fibrotic or subpleural ILA were examined in MESA participants with ILA assessments on full-lung CT 10 years later. Immunohistochemical staining of select proteins was performed in lung tissue from pulmonary fibrosis cases.
MEASUREMENTS AND MAIN RESULTS
There were 75 proteins detected that were significantly associated with HAA in MESA and SPIROMICS. Gene ontology analysis of these proteins identified processes involved in immune cell chemotaxis and cellular growth and apoptosis. Seven proteins were associated with a higher probability of new-onset fibrotic or subpleural ILA in MESA and two of these, junctional adhesion molecule-like protein and GTP cyclohydrolase 1 feedback regulatory protein, stained in areas of fibrosis in lung tissue from patients with ILD.
CONCLUSIONS
Plasma proteins associated with more HAA are involved in immune and cellular processes and associate with new onset fibrotic-subpleural ILA.
期刊介绍:
The American Journal of Respiratory and Critical Care Medicine focuses on human biology and disease, as well as animal studies that contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients. Papers that are solely or predominantly based in cell and molecular biology are published in the companion journal, the American Journal of Respiratory Cell and Molecular Biology. The Journal also seeks to publish clinical trials and outstanding review articles on areas of interest in several forms. The State-of-the-Art review is a treatise usually covering a broad field that brings bench research to the bedside. Shorter reviews are published as Critical Care Perspectives or Pulmonary Perspectives. These are generally focused on a more limited area and advance a concerted opinion about care for a specific process. Concise Clinical Reviews provide an evidence-based synthesis of the literature pertaining to topics of fundamental importance to the practice of pulmonary, critical care, and sleep medicine. Images providing advances or unusual contributions to the field are published as Images in Pulmonary, Critical Care, Sleep Medicine and the Sciences.
A recent trend and future direction of the Journal has been to include debates of a topical nature on issues of importance in pulmonary and critical care medicine and to the membership of the American Thoracic Society. Other recent changes have included encompassing works from the field of critical care medicine and the extension of the editorial governing of journal policy to colleagues outside of the United States of America. The focus and direction of the Journal is to establish an international forum for state-of-the-art respiratory and critical care medicine.